NEVVI Medicare utilization intelligence

← back

BANO, KULSUMMD NPI 1114378775 Clinician

Hematology-Oncology · CHARLOTTE, NC

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 12 years since medical school (class of 2014, self-reported to CMS)
Location CHARLOTTE, NC · NPPES registered location
Active in data Billed Medicare 2020–2024 (3 years)
Scale 43 codes billed · 74,020 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20202026
THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY
2024–2026
CAROLINAS PHYSICIANS NETWORK INC
2020

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-07

Year: 2024 · 2023 · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9264 Injection, paclitaxel protein-bound particles, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0897 Injection, denosumab, 1 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0640 Injection, leucovorin calcium, per 50 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J9190 Injection, fluorouracil, 500 mg
96375 Injection of additional new drug or substance into vein
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
96372 Injection of drug or substance under skin or into muscle
J9045 Injection, carboplatin, 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96374 Injection of drug or substance into vein
83615 Lactate dehydrogenase (enzyme) level
81003 Automated urinalysis test
83735 Magnesium level
96415 Administration of chemotherapy into vein, each additional hour
85007 Microscopic examination for white blood cells with manual cell count
J1200 Injection, diphenhydramine hcl, up to 50 mg
84100 Phosphate level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
83690 Lipase (fat enzyme) level
82150 Amylase (enzyme) level
96411 Administration of additional new drug or substance into vein using push technique
96416 Administration of prolonged chemotherapy into vein
J3490 Unclassified drugs
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
85045 Red blood count, automated test

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.